Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
171
NCT01458847
Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 31, 2009
Completion: Nov 30, 2012
NCT01320579
Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic Dermatitis
Phase: Phase 2
Start: Mar 31, 2011
Completion: Jun 30, 2012